COMMUNIQUÉS West-GlobeNewswire

Solon Eiendom ASA : Primary insider notification
22/01/2018
SOLON EIENDOM ASA STOCK EXCHANGE ANNOUNCEMENT Solon Eiendom ASA - Primary insider notification (Oslo, Norway, January 19, 2018) Solon Eiendom ASA Board Member Tore Aksel Voldberg (through his wholly owned company Skøien [...]
Genmab Announces Novartis’ Intention to Transition Arzerra® (ofatumumab) from Commercial Availability to Limited Availability via Compassionate Use Programs for the Treatment of CLL in Non-US Markets
22/01/2018
Company Announcement Novartis intends to transition the commercial availability of Arzerra to limited availability via compassionate use programs for treatment of CLL in non-US markets. Novartis will continue to market [...]
NANOBIOTIX presents first promising data from Phase I/II Liver Cancers trial of NBTXR3 at the American Society Of Clinical Oncology Gastrointestinal Annual Meeting
22/01/2018
NANOBIOTIX PRESENTS FIRST PROMISING DATA FROM PHASE I/II LIVER CANCERS TRIAL OF NBTXR3 AT THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY GASTROINTESTINAL ANNUAL MEETING Very good safety profile with no AEs and SAEs related [...]
NANOBIOTIX présente de premières données prometteuses dans l'essai de phase I/II avec NBTXR3 dans les cancers du foie à l'ASCO GI
22/01/2018
Nanobiotix présente de premières données prometteuses dans l'essai de phase I/II avec NBTXR3 dans les cancers du foie à l' American Society of Clinical Oncology Gastrointestinal Annual Meeting (ASCO GI) Très bon profil [...]
Immunicum AB (publ) Announces Upcoming Presentations and Attendances at Conferences in January and February
22/01/2018
Press Release 22 January 2018 Immunicum AB (publ) Announces Upcoming Presentations and Attendances at Conferences in January and February Immunicum AB (publ; IMMU.ST) a biopharmaceutical company advancing a novel, [...]
Sanofi to Acquire Bioverativ for $11.6 Billion
22/01/2018
Sanofi to Acquire Bioverativ for $11.6 Billion Expands Sanofi's presence in specialty care and strengthens leadership in rare diseases Adds leader in the growing hemophilia market and provides platform for expansion in [...]
Sanofi va acquérir Bioverativ pour 11,6 milliards de dollars
22/01/2018
Sanofi va acquérir Bioverativ pour 11,6 milliards de dollars Extension de la présence de Sanofi dans la médecine de spécialités et renforcement du leadership de Sanofi dans les maladies rares Acquisition d'un leader [...]
Sanofi to Acquire Bioverativ for $11.6 Billion
22/01/2018
Sanofi to Acquire Bioverativ for $11.6 Billion Expands Sanofi's presence in specialty care and strengthens leadership in rare diseases Adds leader in the growing hemophilia market and provides platform for expansion in [...]
Sanofi va acquérir Bioverativ pour 11,6 milliards de dollars
22/01/2018
Sanofi va acquérir Bioverativ pour 11,6 milliards de dollars Extension de la présence de Sanofi dans la médecine de spécialités et renforcement du leadership de Sanofi dans les maladies rares Acquisition d'un leader [...]
ABLYNX ANNOUNCES WARRANTS EXERCISE AND CONVERSION OF BONDS
22/01/2018
REGULATED INFORMATION GHENT, Belgium, 22 January 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in conformity with Title II of the Law of 2 May 2007 and the Royal Decree of 14 February 2008, that an [...]
Novartis completes tender offer for Advanced Accelerator Applications S.A. and announces commencement of subsequent offering period
22/01/2018
Transaction expands Novartis Oncology neuroendocrine tumor (NET) treatment portfolio and adds radiopharmaceutical technology platform Lutathera® (lutetium Lu 177 dotatate), with a US PDUFA date of January 26, creates [...]
Gala Pharmaceuticals Sees 2018 as Breakthrough Year for Company
21/01/2018
ANAHEIM, Calif., Jan. 21, 2018 (GLOBE NEWSWIRE) -- Gala Pharmaceuticals Inc. (GPI) (OTCBB: GLPH ) today announced that it is focusing on key 2018 goals to drive success and build long-term shareholder value. Gala [...]
CBMG Accelerates Cell Therapy Manufacturing with GE Healthcare’s New Start-to-Finish Solution
20/01/2018
GE supports CBMG in its aim to speed up manufacturing timelines for its CAR T-cell therapy clinical trials and future commercialization First GE Healthcare FlexFactory™ for cell therapy installation in the world [...]
Zealand Pharma announces progress to Phase 3 with dasiglucagon for the treatment of congenital hyperinsulinism in first half 2018
19/01/2018
Company announcement - No. 4/2018 Zealand Pharma announces progress to Phase 3 with dasiglucagon for the treatment of congenital hyperinsulinism in first half 2018 Zealand receives FDA approval of its Investigational [...]
U.S. FDA Grants Priority Review for Daratumumab in Front Line Multiple Myeloma
19/01/2018
Company Announcement U.S. FDA grants Priority Review to daratumumab in combination with bortezomib, melphalan and prednisone for the treatment of patients with newly diagnosed multiple myeloma ineligible for autologous [...]
MEDIA ADVISORY -- Dr. Heinrich Roder, Biodesix CTO, To Speak At Precision Medicine World Conference
19/01/2018
ADVISORY, Jan. 19, 2018 (GLOBE NEWSWIRE) -- WHAT: Dr. Heinrich Roder, Biodesix’ CTO, will speak on “Applied Machine Learning for Immuno-Oncology Diagnostics” in the “AI and Data Science Showcase” track at the Precision [...]
Meridian Bioscience, Inc. Expects to Report First Quarter Fiscal Year 2018 Operating Results on Thursday, January 25, 2018
19/01/2018
CINCINNATI, Jan. 19, 2018 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO ), a leading diagnostic and life science component company, expects to release its first quarter fiscal 2018 operating results before [...]
TiGenix: Transparency Information
19/01/2018
PRESS RELEASE REGULATED INFORMATION Transparency Information Leuven (BELGIUM) - January 19, 2018, 22:00h CET - TiGenix NV (Euronext Brussels and Nasdaq: TIG) publishes information in accordance with articles 15 and 18 [...]
Tonix Pharmaceuticals Announces Publication Reporting Synthesis, Construction and Characterization of a Potential Smallpox-Preventing Vaccine Candidate TNX-801 (Live Horsepox Virus from Cell Culture)
19/01/2018
NEW YORK, Jan. 19, 2018 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP ) (Tonix), a company developing innovative pharmaceutical and biological products to address major public health challenges, [...]

Pages